To explore main cause and health impact of iodine excess during pregnancy, we performed iodine evaluation for 390 consecutive pregnant women from January 1st, 2016 to December 31st, 2016. Among them, 18 women (4.62%) with apparently elevated urinary iodine concentration (UIC) were enrolled onto this study for subsequent follow-up. History of high iodine exposure was collected from all participants. Parameters about iodine status were monitors until termination of pregnancy, and dietary iodine intake condition and thyroid function were also evaluated.
A prospective follow-up was arranged for the 18 pregnant women with excessive iodine status. History of iodine exposure (including hysterosalpingography (HSG) using an oil-soluble iodinated contrast medium, examination by computed tomography scan with contrast, administration of amiodarone, history of receiving radioiodine therapy, etc.) was collected from all participants. Evaluation of dietary iodine intake was performed through a 72-hour dietary recall.The serum iodine concentration (SIC) and urinary iodine concentration (UIC) were monitored continuously in the whole course of pregnancy. All subjects with excessive iodine load were recommended by nutritionists to have their dietary iodine intake restricted, and resume iodine-containing supplements and foods until the UIC\<250 μg/L and SIC≤90 μg/L. After delivery, maternal colostrum iodine concentration and neonatal iodine status (including neonatal UIC, condition of congenital hypothyroidism screening tests, and thyroid physical examination) were also assessed.
Study Type
OBSERVATIONAL
Enrollment
18
All subjects with excessive iodine load were recommended by nutritionists to restrict dietary iodine intake, and resume iodine-containing supplements and foods until their iodine status return to normal. However, in this observational study, the intervention was a regular management in prenatal care, and not assigned by investigator of the study.
prevalence of adverse pregnancy outcome
prevalence of stillbirth, abortion and other adverse pregnancy outcome
Time frame: 6-9 months post identification of maternal iodine excess
composite neonatal outcome
Apgar scores, birth weight of the neonates,and prevalence of thyroid dysfunction in neonates
Time frame: 6-9 months post identification of maternal iodine excess
prevalence of maternal thyroid dysfunction in pregnancy
Laboratory reference ranges of TSH during pregnancy were 0.1\~2.5 mIU/L for the first trimester, 0.2\~3.0 mIU/L for the second trimester and 0.3\~3.0 mIU/L for the third trimester.Prevalence of TSH elevation during pregnancy will be summarized.
Time frame: through study completion, about 6-9 months post identification of maternal iodine excess
prevalence of neonatal iodine excess
urinary iodine concentration will be examined for all neonates born to women with iodine excess in pregnancy, and prevalence of neonatal urinary iodine concentration ≥ 200μg/L will be summarized.
Time frame: within 1 week after birth
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.